Study trial flow diagram.
CYTOMEGALOVIRUS, VASODILATATION
CONSORT diagram of the anticipated number of participants that need to be screened in order to reach a target of 80 participants randomized to atorvastatin or placebo.Participants receive either 48 weeks of 20 mg atorvastatin or placebo once daily. We use oral atorvastatin 20 mg capsule in generic form and a placebo capsule prepared by the hospital pharmacist, composed of starch which is similar to atorvastatin capsule in size, shape, and color. Packagings are identical in appearance for both atorvastatin and the placebo. CMV = cytomegalovirus; DAA = direct-acting antiviral; LDL = low density lipid; CIMT = carotid intima media thickness; FMD = flow mediated vasodilatation; CAP = controlled attenuation parameter.